Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Are There Socio-Demographic Inequalities in the Utilisation of Tumour and ctDNA Somatic Mutation Testing in Solid Tumours? A Systematic Review.

Cancer medicine - 1 Mar 2026

Rae Sarah, Baldwin Annie, Lagonera Maria Julia, Norris Ruth, Greystoke Alastair, Sharp Linda

Abstract excerpt

INTRODUCTION: Somatic mutation testing in solid tumours represents a rapidly advancing field which increases opportunities for access to molecularly targeted therapeutics and clinical trials. This systematic review determined whether socio-demographic inequalities affect utilisation of novel somatic mutation testing. METHODS: Following PRISMA 2020 guidance, MEDLINE, EMBASE, Scopus, CINAHL, Web of Science, PubMed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Circulating Tumor DNA
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Healthcare Disparities

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Share to Neoplasms

Share to Socioeconomic Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 41830052
DOI: 10.1002/cam4.71668
PMCID: PMC13093295

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Are There Socio-Demographic Inequalities in the Utilisation of Tumour and ctDNA Somatic Mutation Testing in Solid Tumours? A Systematic Review.PMID 41830052Read ↗

Factors influencing cancer genetic somatic mutation test ordering by cancer physician.Semantic proximity Read ↗

Factors Influencing Cancer Genetic Somatic Mutation Test Ordering By Cancer PhysiciansSemantic proximity Read ↗

Next-Generation Sequencing Trends among Adult Patients with Select Advanced Tumor Types: A Real-World Evidence Evaluation.Semantic proximity Read ↗

Real-world patterns on tumor mutation burden testing in a pan-tumor population.Semantic proximity Read ↗

Variations in Genomic Testing in Non-small Cell Lung Carcinoma: A Healthcare Professional Survey of Current Practices in the UK.Semantic proximity Read ↗

Sociodemographic and clinical factors associated with receipt of biomarker testing in patients with metastatic colorectal cancer.Semantic proximity Read ↗

Socioeconomic and Clinical Determinants Driving Access to BRCA Genetic Testing in Cancer : A Case-Control Study Using Observational Electronic Health Records Across Multiple SitesSemantic proximity Read ↗

Underutilization and disparities in access to EGFR testing among Medicare patients with lung cancer from 2010 - 2013.Semantic proximity Read ↗

Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy.Semantic proximity Read ↗

Socioeconomic Determinants of the Use of Molecular Testing in Stage IV Colorectal Cancer.Semantic proximity Read ↗

Trends in Use of Next-Generation Sequencing in Patients With Solid Tumors by Race and Ethnicity After Implementation of the Medicare National Coverage Determination.Semantic proximity Read ↗

BRCA testing utilization among commercially insured women with breast or ovarian cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.